)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
ENDRA Life Sciences
ENDRA Life Sciences (NDRA) investor relations material
ENDRA Life Sciences Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary31 Mar, 2026
Executive summary
Initiated a strategic alternatives review to maximize shareholder value, with no set timetable for completion.
Achieved significant clinical milestones for TAEUS Liver, demonstrating strong correlation with MRI-PDFF and robust repeatability, supporting its use in clinical practice and pharmaceutical trials.
Financial highlights
Operating expenses for Q4 2025 decreased to $1.6M from $4.3M in Q4 2024; full-year 2025 operating expenses fell to $5.8M from $10.8M in 2024.
Net loss for Q4 2025 was $3.2M, improved from $4.2M in Q4 2024; full-year net loss was $7.0M, down from $11.5M in 2024.
Cash used in operations in Q4 2025 increased to $1.6M from $1.5M in Q4 2024.
As of December 31, 2025, cash and cash equivalents were $762K, with an additional $2.0M in digital assets.
Outlook and guidance
Continued execution of strategic and operating initiatives during the strategic review process.
Management remains confident in the long-term potential of TAEUS Liver and its value proposition for patients, clinicians, and shareholders.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from ENDRA Life Sciences
- Q2 saw a $7.3M raise, 26% expense cut, narrowed loss, and leadership changes amid ongoing risks.NDRA
Q2 202423 Jan 2026 - Pursuing a dual strategy of medical imaging innovation and major cryptocurrency investment.NDRARegistration Filing16 Dec 2025
- Key votes include director elections, share authorization, reverse split, and auditor ratification.NDRAProxy Filing2 Dec 2025
- Shareholders will vote on director elections, share increases, a reverse split, and warrant issuances.NDRAProxy Filing2 Dec 2025
- Shareholders will vote on director elections, compensation, auditor, share increase, and governance changes.NDRAProxy Filing2 Dec 2025
- Facing Nasdaq delisting, a reverse stock split will be proposed to regain compliance.NDRAProxy Filing2 Dec 2025
- Shareholders to vote on a reverse stock split to help maintain Nasdaq listing and increase share price.NDRAProxy Filing2 Dec 2025
- Vote sought on a reverse stock split to maintain Nasdaq listing and avoid delisting risk.NDRAProxy Filing2 Dec 2025
- Six key proposals—including a 50-fold share authorization increase—are up for shareholder vote.NDRAProxy Filing2 Dec 2025
Next ENDRA Life Sciences earnings date
Q1 202614 May, 2026
ENDRA Life Sciences
Next ENDRA Life Sciences earnings date
Q1 202614 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage